StockTipsArenaBeta

BUY Marksans Pharma Limited — Choice Broking

BUYMarksans Pharma Limited
Marksans Pharma share price target & all analyst calls

byChoice BrokingHorizon: NA (inferred 1–3 months)18 Aug 2026via Economic Times Stock Recos Overview

Entry₹332Inferred
Target₹385
Total upside +15.96%
Stop lossNot given
CMP₹298.1513h ago
Active-10.20%+29.13%upside left 4 wk left
Follow Choice Broking for new callsGet alertsWatch MARKSANS for new buy/sell callsGet alertsSee 32 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:46 am IST
6 supporting5 neutral1 opposing
Supports the BUY call (6)

RSI at 25 — oversold territory

Technicals · rsi·21 Oct · today

1 advisor has an active long-term BUY call on this stock

Advisor consensus · adjacent horizon·31 Aug · 2mo ago

Neutral / worth noting (5)

Q2 FY27 results scheduled — board meets 04 Nov 2026

BSE · Board Meeting·In 13 days

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·21 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Marksans Pharma

All analyst calls on Marksans Pharma

More from Choice Broking

Every call and its outcome